Methoxetamine

3-MeO-2'-Oxo-PCE

MXE, Mexxy

Psychoactive Class

Chemical Class

Methoxetamine is a dissociative substance of the arylcyclohexylamine class, structurally related to ketamine and PCP.¹² It was intentionally designed as a possible therapy for phantom limb syndrome and first appeared on grey markets in late 2010. MXE was noted for its ketamine-like dissociative effects with a pronounced psychedelic character. Once widely available as a research chemical, it is now considered largely extinct due to global bans on its production.

Dosage & Duration

Dosage

Threshold~10 mg

Light10-25 mg

Moderate25-45 mg

Strong45-70 mg

Heavy70+ mg

High doses can cause nausea and vomiting near the peak. Compulsive redosing has been reported and may lead to overdose.

Duration

Onset15-30 minutes

Come Up45-90 minutes

Peak1.5-2.5 hours

Offset1-1.5 hours

After Effects6-48 hours

Total4-6 hours

Subjective Effects

Effects vary widely by individual, dose, and context.

Physical

Tactile disconnectionPhysical autonomy

Cognitive

The general head space of MXE is often described as particularly euphoric and clear headed in comparison to that of DXM and Ketamine.

Consciousness disconnection Ego suppression, loss and death Time distortion Euphoria Introspection Déjà vu Personal bias suppression Conceptual thinking Direct communication with the subconscious Unity and interconnectedness

Visual

Distortions

MXE exhibits a full array of dissociative distortions and alterations in visual perception.

Perspective distortions Environmental cubismEnvironmental orbismScenery slicing

Geometry

The visual geometry found within MXE can be described as very psychedelic when compared to that of Ketamine but not as complex as that of DXM. It does not extend beyond level 5 and can be comprehensively described as simplistic in complexity, algorithmic in style, synthetic in feel, unstructured in organization, dimly lit in lighting, multicoloured in scheme, glossy in shading, soft in edges, large in size, fast in speed, smooth in motion, equal in rounded and angular corners, immersive in depth and consistent in intensity.

Hallucinatory States

At high dosages, MXE can produce a full range of high level hallucinatory states in a fashion that is less consistent and reproducible than that of many other commonly used psychedelics.

Suppressions

This substance does not enhance visual stimuli; instead it tends to degrade and decrease visual aptitude in a variety of ways.

Visual acuity suppression

Auditory

The auditory effects of MXE are common in their occurrence and exhibit a range of effects.

Enhancements Suppression Distortions Hallucinations

Forked from Subjective Effect Documentation

by Josie KinsOctober 2012.

Reagent Testing

Loading reagent data

Expected colorimetric results are being prepared.

Pharmacology

Pharmacodynamics

MXE acts primarily as a high-affinity NMDA receptor antagonist at the dizocilpine (MK-801) binding site (Ki = 257 nM). It also functions as a serotonin reuptake inhibitor with moderate affinity (Ki = 479 nM), while showing negligible activity at the dopamine and norepinephrine transporters (Ki > 10,000 nM). Despite this lack of direct dopamine transporter activity, MXE has been found to activate dopaminergic neurotransmission in the mesolimbic reward pathway, a property shared with other NMDA receptor antagonists. The compound shows insignificant direct affinity for the μ-opioid receptor. The (S)- and (R)-enantiomers appear to contribute differently to the overall profile, with the (S)-enantiomer showing potent NMDA receptor activity and the (R)-enantiomer primarily associated with serotonin reuptake inhibition.

Pharmacokinetics

Limited pharmacokinetic data is available for MXE. O-demethylation of the methoxy group has been identified as a metabolic pathway³, producing a hydroxylated metabolite that may possess enhanced NMDA receptor activity. In-vivo metabolites may exhibit pharmacological properties distinct from the parent compound, including possible opioid receptor activity.

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

AlcoholAMTDiphenhydramineGHB/GBLLithiumOpioidsTramadol

Unsafe

Avoid

There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.

DXMMAOIs

Caution

Use caution

These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.

2C-T-x compoundsAmphetaminesBenzodiazepinesCocaineDOx compoundsMDMANBOMe compoundsPCPPregabalinSSRIs

TripSit

Tolerance

Full Tolerance

Many MXE effects can become less responsive after sustained repeated use. The pace varies considerably by person; some users report tolerance building over weeks, while others notice substantial tolerance after a single night of heavy consumption.

Baseline Reset

1-2 weeks, though some reports suggest that heavy use patterns may require a month or more for complete tolerance reset.

Half Tolerance

3-7 days

Cross Tolerance

Dissociatives (ketamine, PCP, DXM, and related compounds)

Harm Potential

Addiction & Dependence

Psychological

Moderate

MXE is considered moderately addictive with a high potential for abuse and is capable of producing psychological dependence among certain users.⁴ Multiple reports describe it as 'more-ish' with tendencies toward compulsive redosing, and cases of daily habitual use have been documented across online communities.⁴

Physical

Low

MXE does not appear to be physically addictive. However, when psychological dependence has developed, some withdrawal effects may occur upon sudden cessation of use.

Toxicity

Urinary System

Repeated heavy use over extended periods may cause bladder and urinary tract problems similar to those seen with ketamine, including urinary frequency, urgency, pelvic pain, and hematuria; MXE's higher potency means smaller doses are required, potentially reducing but not eliminating this risk with chronic abuse patterns.⁵

Central Nervous System

Acute reversible cerebellar toxicity has been documented in overdose cases, with symptoms lasting one to four days after exposure; this appears to be associated with high-dose or combined consumption rather than typical recreational use.⁶

Cardiovascular

Animal research suggests potential harmful effects on the cardiovascular system; individuals with pre-existing cardiovascular conditions should exercise particular caution.⁷

History & Culture

Design and Synthesis

Methoxetamine represents a deliberate exercise in rational drug design rather than accidental discovery.⁸ The compound was conceived by an anonymous chemist who sought to create a ketamine analogue with improved therapeutic…

Trip Reports

Legality

International

1961 Convention: not internationally scheduled.

1971 Convention: not internationally scheduled.

1988 Convention: not internationally scheduled.

By Country

United StatesIllegalSchedule I

Schedule I⁵¹⁵²

Federally scheduled on July 6, 2022 under the Controlled Substances Act.⁵³ Prior to federal scheduling, multiple states enacted their own controls including Alabama (2015), Arizona (2014), Florida (2012), Indiana (2012), Louisiana (2013), Minnesota (2012), North Dakota (2012), Ohio (2012), Virginia (2012), and Utah.

BrazilIllegalLista F2

Controlled (Portaria SVS/MS nº 344)¹³

Listed as a controlled substance on February 18, 2014 alongside several other novel psychoactive substances. Possession, production, and sale are illegal.

ChileIllegalArticle 1

Decreto Supremo No. 867 de 2007, Reglamento de la Ley No. 20.000, Article 1 (current consolidated text effective 16 September 2023)¹⁴¹⁵

Chile’s current consolidated text of Decreto Supremo No. 867 lists 2-(3-metoxifenil)-2-(etilamino)ciclohexanona (Metoxetamina) in Article 1. Article 1 classifies its listed substances as narcotic or psychotropic drugs capable of producing physical or psychological dependence and serious toxic effects or considerable harm to health, for the purposes of Article 1(1) of Law No. 20.000.

ColombiaRestrictedGreen List II

Resolución No. 116 de 2026, Ministerio de Salud y Protección Social¹⁶

Metoxetamina (MXE) is listed in Colombia’s Green List II of psychotropic substances.

CyprusIllegalClass B · paragraph 18

Controlled¹⁸

Listed in the national drug control law since 2012. Possession, production, and distribution are prohibited.

DenmarkIllegalListe B

Controlled²⁰

Covered by the Executive Order on Euphoriant Substances, making possession, production, and distribution illegal.

FranceIllegalAnnexe IV

Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants²²²³

Methoxetamine is classified as a stupéfiant in Annex IV of France's national list of narcotic substances. The classification places methoxetamine under France's narcotics-control regime.

IndiaIllegalSchedule · No. 110N

Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule (section 2(xxiii))²⁵

Methoxetamine (MXE) is expressly listed at serial no. 110N in the Schedule of psychotropic substances to India's Narcotic Drugs and Psychotropic Substances Act, 1985. The Central Bureau of Narcotics' official Schedule compilation records the listing's insertion by S.O. 821(E) of 27 February 2018. This is a direct listing of methoxetamine and MXE, rather than control based only on an analogue or product category.

IrelandIllegalSchedule 1

Misuse of Drugs (Designation) (Amendment) (No. 2) Order 2014, S.I. No. 584/2014²⁸

Methoxetamine is designated as a controlled drug in Ireland’s Misuse of Drugs regime.

JapanIllegal麻薬

Narcotic³⁰

Classified as a narcotic drug effective June 26, 2016. Earlier controls from July 2012 restricted importation, production, and distribution while possession for personal use remained in a legal grey area.

NetherlandsIllegalLijst I

List I (Opiumwet)³²

Added to List I of the Opium Law in July 2015. Possession, production, transport, import, export, and sale are prohibited.

PhilippinesIllegalSchedule II

Dangerous Drugs Board, Updated Lists of Controlled Substances, under Republic Act No. 9165³⁴

Methoxetamine (MXE) is listed in the Philippines’ official controlled-substances schedule.

RussiaControlled

Prohibited since October 2011. Possession, production, and sale are illegal under Russian narcotics legislation.

SloveniaIllegalI. skupina

Controlled³⁹

Listed as a controlled substance per Official Gazette of the Republic of Slovenia No. 62/2013.

SwedenIllegalFörteckning I

Narcotic⁴¹⁴²

Controlled under the Narcotic Drugs Control Act (SFS 1992-860) and the Narcotic Drugs Control Ordinance (SFS 1994:1554).

ThailandIllegalCategory 1

Ministerial Regulation Specifying Category 1 Narcotics under the Narcotics Code B.E. 2565 (2022)⁴³

Methoxetamine (MXE) is listed as a Category 1 narcotic in Thailand.

UkraineIllegalTable I · List 2

Cabinet of Ministers Resolution No. 770 of 6 May 2000, as amended by Cabinet of Ministers Resolution No. 600 of 10 July 2019⁴⁴⁴⁵

Ukraine's current official schedule lists Метоксетамін (MXE, 3-Meo-2-Oxo-PCE) in Table I, List 2. That list is for especially dangerous psychotropic substances whose circulation is prohibited. Resolution No. 600 of 10 July 2019 standardized the substance's name and synonym in the schedule.

AustriaIllegalAnhang IV.1

Illegal (SMG)¹¹

Prohibited under the Suchtmittelgesetz since June 26, 2019.¹² Possession, production, and sale are criminal offenses.

CanadaSchedule I CDSA (analogue)

Health Canada declared MXE a controlled analogue of ketamine under Schedule I of the Controlled Drugs and Substances Act in January 2011. Possession, production, and sale are prohibited.

ChinaCategory I Psychotropic

Controlled as a Category I psychotropic substance. It is illegal to sell, buy, import, export, or manufacture without authorization. China's ban on production significantly impacted global MXE availability.

CroatiaIllegalOdjeljak 1

Popis droga, psihotropnih tvari i biljaka iz kojih se može dobiti droga te tvari koje se mogu uporabiti za izradu droga¹⁷

Methoxetamine (metoksetamin; MXE) is expressly listed in Odjeljak 1 of Croatia's official list of drugs, psychotropic substances, and plants from which drugs may be obtained. The listing identifies methoxetamine by its chemical name, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone, and places it under Croatia's controlled-drugs regime.

Czech RepublicIllegalAnnex 4

Nařízení vlády č. 463/2013 Sb., o seznamech návykových látek, current consolidated text effective 25 June 2026¹⁹

The current official consolidated text of Government Regulation No. 463/2013 Sb. lists Methoxetamin (MXE), with the chemical name 2-(ethylamino)-2-(3-methoxyfenyl)cyklohexanon, in Annex No. 4, the list of psychotropic substances. The regulation classifies Annex No. 4 as a list of psychotropic substances and states that it includes additional psychotropic substances whose handling is permitted only for limited research, scientific, and very limited therapeutic purposes specified in a handling authorization. The listing applies directly to methoxetamine rather than only to an analogue or a specified product.

FinlandIllegalNarcotic

Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008²¹

Metoksetamiini is included in Finland’s official narcotics schedule.

GermanyIllegalAnlage I

Anlage I BtMG²⁴

Controlled under the Betäubungsmittelgesetz since July 2013.²⁴ Manufacturing, importing, possessing, selling, or transferring without license is prohibited.

IndonesiaIllegalNarcotics Group I

Peraturan Menteri Kesehatan Republik Indonesia Nomor 15 Tahun 2025 tentang Perubahan Penggolongan Narkotika²⁶²⁷

Methoxetamine (Metoksetamina; MXE) is expressly listed as item 102 in Indonesia’s Group I narcotics schedule. Group I narcotics may be used only for scientific development, not therapy, and have a very high dependence potential.

ItalyIllegalTabella I

Controlled²⁹

Listed in the table of controlled drugs since 2016. Possession, production, and distribution are prohibited.

MexicoRestrictedImport/export

Acuerdo que modifica el diverso que establece las mercancías cuya importación y exportación está sujeta a regulación por parte de la Secretaría de Salud³¹

Metoxetamina is named in Mexico’s official health-secretariat import and export control list.

NorwayIllegalP II

Forskrift om narkotika (narkotikaforskriften), FOR-2013-02-14-199³³

Metoksetamin is included in Norway’s narcotics list and marked prohibited under section 5.

PortugalDecriminalizedTable II-A

Decreto-Lei n.º 15/93, Table II-A, as amended by Lei n.º 7/2017, de 2 de março; Lei n.º 30/2000³⁵³⁶³⁷

Methoxetamine is expressly listed in Table II-A of Portugal’s controlled-substances schedules through Lei n.º 7/2017. For scheduled substances, personal consumption, acquisition, and possession for personal use are administrative offences under Lei n.º 30/2000; the controlled-substances regime otherwise remains applicable.

SingaporeIllegalFourth Schedule · 1(17)(28)

Misuse of Drugs Regulations, Fourth Schedule, paragraph 1(17)(28)³⁸

Methoxetamine is expressly listed as a controlled drug in paragraph 1(17)(28) of the Fourth Schedule to Singapore's Misuse of Drugs Regulations. The Fourth Schedule subjects controlled drugs to the requirements in regulations 10, 11, 12, 13, 14, 15 and 28.

SpainIllegalList II

Orden SSI/1091/2015, de 2 de junio, including substances in List II of Annex I to Real Decreto 2829/1977⁴⁰

Metoxetamina is included in List II of Spain’s controlled-substances schedule and is subject to the applicable control measures and criminal sanctions.

SwitzerlandControlled (Verzeichnis D)

Specifically named under Verzeichnis D of the Swiss narcotics legislation. Possession, production, and sale are illegal.

TurkeyControlled

Regulated under the Law on Control of Narcotics no. 2313. Unauthorized possession, production, and distribution are prohibited.

United KingdomIllegalClass B · Schedule 1

Class B⁴⁶⁴⁷

Permanently classified in February 2013 following a Temporary Class Drug Order issued in April 2012.⁴⁸⁴⁹ The Advisory Council on the Misuse of Drugs recommended scheduling after reviewing emerging evidence of harm.⁵⁰

References

Source Pages

Citations

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Methoxetamine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Methoxetamine

3-MeO-2'-Oxo-PCE

MXE, Mexxy

Psychoactive Class

Dissociative Hallucinogen

Chemical Class

Arylcyclohexylamine

Dosage & Duration

Dosage

Threshold~10 mg

Light10-25 mg

Moderate25-45 mg

Strong45-70 mg

Heavy70+ mg

High doses can cause nausea and vomiting near the peak. Compulsive redosing has been reported and may lead to overdose.

Duration

Onset15-30 minutes

Come Up45-90 minutes

Peak1.5-2.5 hours

Offset1-1.5 hours

After Effects6-48 hours

Total4-6 hours

Subjective Effects

Effects vary widely by individual, dose, and context.

Physical

Tactile disconnectionPhysical autonomy

Cognitive

The general head space of MXE is often described as particularly euphoric and clear headed in comparison to that of DXM and Ketamine.

Visual

Distortions

MXE exhibits a full array of dissociative distortions and alterations in visual perception.

Perspective distortions Environmental cubismEnvironmental orbismScenery slicing

Geometry

Hallucinatory States

At high dosages, MXE can produce a full range of high level hallucinatory states in a fashion that is less consistent and reproducible than that of many other commonly used psychedelics.

Suppressions

This substance does not enhance visual stimuli; instead it tends to degrade and decrease visual aptitude in a variety of ways.

Visual acuity suppression

Auditory

The auditory effects of MXE are common in their occurrence and exhibit a range of effects.

Enhancements Suppression Distortions Hallucinations

Forked from Subjective Effect Documentation

by Josie KinsOctober 2012.

Reagent Testing

Loading reagent data

Expected colorimetric results are being prepared.

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

AlcoholAMTDiphenhydramineGHB/GBLLithiumOpioidsTramadol

Unsafe

Avoid

There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.

DXMMAOIs

Caution

Use caution

2C-T-x compoundsAmphetaminesBenzodiazepinesCocaineDOx compoundsMDMANBOMe compoundsPCPPregabalinSSRIs

TripSit

Tolerance

Full Tolerance

Baseline Reset

1-2 weeks, though some reports suggest that heavy use patterns may require a month or more for complete tolerance reset.

Half Tolerance

3-7 days

Cross Tolerance

Dissociatives (ketamine, PCP, DXM, and related compounds)

Harm Potential

Addiction & Dependence

Psychological

Moderate

Physical

Low

MXE does not appear to be physically addictive. However, when psychological dependence has developed, some withdrawal effects may occur upon sudden cessation of use.

Toxicity

Urinary System

Central Nervous System

Cardiovascular

Animal research suggests potential harmful effects on the cardiovascular system; individuals with pre-existing cardiovascular conditions should exercise particular caution.⁷

History & Culture

Design and Synthesis

Trip Reports

The Expeditionon 22/02/2016— nervewing

Trip Reports

Legality

International

1961 Convention: not internationally scheduled.

1971 Convention: not internationally scheduled.

1988 Convention: not internationally scheduled.

By Country

United StatesIllegalSchedule I

Schedule I⁵¹⁵²

BrazilIllegalLista F2

Controlled (Portaria SVS/MS nº 344)¹³

Listed as a controlled substance on February 18, 2014 alongside several other novel psychoactive substances. Possession, production, and sale are illegal.

ChileIllegalArticle 1

Decreto Supremo No. 867 de 2007, Reglamento de la Ley No. 20.000, Article 1 (current consolidated text effective 16 September 2023)¹⁴¹⁵

ColombiaRestrictedGreen List II

Resolución No. 116 de 2026, Ministerio de Salud y Protección Social¹⁶

Metoxetamina (MXE) is listed in Colombia’s Green List II of psychotropic substances.

CyprusIllegalClass B · paragraph 18

Controlled¹⁸

Listed in the national drug control law since 2012. Possession, production, and distribution are prohibited.

DenmarkIllegalListe B

Controlled²⁰

Covered by the Executive Order on Euphoriant Substances, making possession, production, and distribution illegal.

FranceIllegalAnnexe IV

Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants²²²³

Methoxetamine is classified as a stupéfiant in Annex IV of France's national list of narcotic substances. The classification places methoxetamine under France's narcotics-control regime.

IndiaIllegalSchedule · No. 110N

Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule (section 2(xxiii))²⁵

IrelandIllegalSchedule 1

Misuse of Drugs (Designation) (Amendment) (No. 2) Order 2014, S.I. No. 584/2014²⁸

Methoxetamine is designated as a controlled drug in Ireland’s Misuse of Drugs regime.

JapanIllegal麻薬

Narcotic³⁰

NetherlandsIllegalLijst I

List I (Opiumwet)³²

Added to List I of the Opium Law in July 2015. Possession, production, transport, import, export, and sale are prohibited.

PhilippinesIllegalSchedule II

Dangerous Drugs Board, Updated Lists of Controlled Substances, under Republic Act No. 9165³⁴

Methoxetamine (MXE) is listed in the Philippines’ official controlled-substances schedule.

RussiaControlled

Prohibited since October 2011. Possession, production, and sale are illegal under Russian narcotics legislation.

SloveniaIllegalI. skupina

Controlled³⁹

Listed as a controlled substance per Official Gazette of the Republic of Slovenia No. 62/2013.

SwedenIllegalFörteckning I

Narcotic⁴¹⁴²

Controlled under the Narcotic Drugs Control Act (SFS 1992-860) and the Narcotic Drugs Control Ordinance (SFS 1994:1554).

ThailandIllegalCategory 1

Ministerial Regulation Specifying Category 1 Narcotics under the Narcotics Code B.E. 2565 (2022)⁴³

Methoxetamine (MXE) is listed as a Category 1 narcotic in Thailand.

UkraineIllegalTable I · List 2

Cabinet of Ministers Resolution No. 770 of 6 May 2000, as amended by Cabinet of Ministers Resolution No. 600 of 10 July 2019⁴⁴⁴⁵

AustriaIllegalAnhang IV.1

Illegal (SMG)¹¹

Prohibited under the Suchtmittelgesetz since June 26, 2019.¹² Possession, production, and sale are criminal offenses.

CanadaSchedule I CDSA (analogue)

Health Canada declared MXE a controlled analogue of ketamine under Schedule I of the Controlled Drugs and Substances Act in January 2011. Possession, production, and sale are prohibited.

ChinaCategory I Psychotropic

CroatiaIllegalOdjeljak 1

Popis droga, psihotropnih tvari i biljaka iz kojih se može dobiti droga te tvari koje se mogu uporabiti za izradu droga¹⁷

Czech RepublicIllegalAnnex 4

Nařízení vlády č. 463/2013 Sb., o seznamech návykových látek, current consolidated text effective 25 June 2026¹⁹

FinlandIllegalNarcotic

Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008²¹

Metoksetamiini is included in Finland’s official narcotics schedule.

GermanyIllegalAnlage I

Anlage I BtMG²⁴

Controlled under the Betäubungsmittelgesetz since July 2013.²⁴ Manufacturing, importing, possessing, selling, or transferring without license is prohibited.

IndonesiaIllegalNarcotics Group I

Peraturan Menteri Kesehatan Republik Indonesia Nomor 15 Tahun 2025 tentang Perubahan Penggolongan Narkotika²⁶²⁷

ItalyIllegalTabella I

Controlled²⁹

Listed in the table of controlled drugs since 2016. Possession, production, and distribution are prohibited.

MexicoRestrictedImport/export

Acuerdo que modifica el diverso que establece las mercancías cuya importación y exportación está sujeta a regulación por parte de la Secretaría de Salud³¹

Metoxetamina is named in Mexico’s official health-secretariat import and export control list.

NorwayIllegalP II

Forskrift om narkotika (narkotikaforskriften), FOR-2013-02-14-199³³

Metoksetamin is included in Norway’s narcotics list and marked prohibited under section 5.

PortugalDecriminalizedTable II-A

Decreto-Lei n.º 15/93, Table II-A, as amended by Lei n.º 7/2017, de 2 de março; Lei n.º 30/2000³⁵³⁶³⁷

SingaporeIllegalFourth Schedule · 1(17)(28)

Misuse of Drugs Regulations, Fourth Schedule, paragraph 1(17)(28)³⁸

SpainIllegalList II

Orden SSI/1091/2015, de 2 de junio, including substances in List II of Annex I to Real Decreto 2829/1977⁴⁰

Metoxetamina is included in List II of Spain’s controlled-substances schedule and is subject to the applicable control measures and criminal sanctions.

SwitzerlandControlled (Verzeichnis D)

Specifically named under Verzeichnis D of the Swiss narcotics legislation. Possession, production, and sale are illegal.

TurkeyControlled

Regulated under the Law on Control of Narcotics no. 2313. Unauthorized possession, production, and distribution are prohibited.

United KingdomIllegalClass B · Schedule 1

Class B⁴⁶⁴⁷

References

Source Pages

Citations

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Methoxetamine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Methoxetamine

Contents

Dosage & Duration

Dosage

Duration

Subjective Effects

Physical

Cognitive

Visual

Distortions

Geometry

Hallucinatory States

Suppressions

Auditory

Reagent Testing

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Unsafe

Caution

Tolerance

Harm Potential

Addiction & Dependence

Psychological

Physical

Toxicity

History & Culture

Design and Synthesis

Trip Reports

Legality

International

By Country

References

Source Pages

Citations

Further Reading

Suggest an edit

Methoxetamine

Contents

Dosage & Duration

Dosage

Duration

Subjective Effects

Physical

Cognitive

Visual

Distortions

Geometry

Hallucinatory States

Suppressions

Auditory

Reagent Testing

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Dangerous

Unsafe

Caution

Tolerance

Harm Potential

Addiction & Dependence

Psychological

Physical

Toxicity

History & Culture

Design and Synthesis

Trip Reports

Trip Reports

Legality

International

By Country

References

Source Pages

Citations

Further Reading

Suggest an edit

Trip Reports